A lthough the function of p27 has been extensively studied in various cancers 1, 2 and in organ development 3, 4 , the effects of p27 on myocardial infarction (MI) remain incompletely understood. As a terminally differentiated organ, the adult mammalian heart has very limited regenerative capacity 5 , and high levels of p27 kip1 (p27) have been observed in cardiomyocytes. However, the hearts of neonatal rodents and of humans of up to 7 months of age retain proliferative capacity 6 . Cardiomyocytes subsequently lose the ability to divide; they switch from hyperplastic to hypertrophic as they withdraw from the cell cycle and remain in the G0 stage of the cell cycle indefinitely [7] [8] [9] . As previously reported, p27 haplo-insufficient and deficient mice exhibit pro-angiogenesis action and overall increased growth of various organs, including heart, spleen, and liver compared with wild type (WT) mice 10, 11 and possibly exhibit increased re-entry of adult cardiomyocytes into the cell cycle after injury 12, 13 . The incidence of heart attacks, especially those due to myocardial infarction has rapidly increased worldwide. MI leads to a poor prognosis 14 , and it is crucial to restore the ischemic area blood flow immediately and preserve the ischemic myocardium. Therapeutic angiogenesis by autocrine and paracrine signaling is widely accepted in academic fields 15 , including the use of a variety of angiogenic cytokines, which play an initial role in counteracting hypoxia and ischemia and in regulating the microenvironment by increasing collateral vascular growth, promoting cardiomyocyte proliferation and limiting fibrosis in the affected area. Currently, animal and clinical data indicate that the transfer of genes for angiogenic factors, including FGF [16] [17] [18] , vascular endothelial growth factor (VEGF) [19] [20] [21] , angiopoietin 21, 22 and hepatocyte growth factor (HGF) 23 , into the ischemic myocardium can induce pro-angiogenesis action and improve cardiac function. Interestingly, in many cancer tissues, VEGF, HGF and p27 can interact to regulate angiogenesis or lead to the redistribution of blood vessels [24] [25] [26] . Evidence shows that hypoxia and serum deprivation decrease p27 expression 27 and that low levels of p27 expression increased VEGF 26 and HGF 25 production. Following myocardial ischemia, NF-kB is a key regulator of inflammatory and survival pathways and is activated by increased IKK activation. At the early stage of injury, including the development of ischemia and hypoxia, inflammation is an automatic trigger that counteracts negative factors and maintains biological function. NF-kB is thought to be an intracellular messenger that transmits the gene induction signal from the cytoplasm to the nucleus. Importantly, although the location of the NF-kB binding site-like element in the HGF gene is far from the major transcription initiation site, the HGF gene also is activated by the production of NF-kB, which is induced by a variety of factors, including TNF-a, IL-1 and TPA 28 . VEGF is widely known as a downstream factor in the NF-kB pathway. Huang and co-workers reported that low levels of p27 expression promote IKK/NF-kB p65 activation 29 . Among the molecular mechanisms involved, cell cycling and inflammation are of paramount importance not only for protecting the cells but also for improving angiogenesis; thus, the various effects of VEGF and HGF are important for the repair of heart injury. However, few studies have examined the relationships between p27, NF-kB, VEGF and HGF in MI.
In the present study, we examined whether p27 haplo-insufficiency affects the progression of MI in mice. After ligation of the left anterior descending (LAD) coronary artery, echocardiography was used to investigate the cardiac function of p27 haplo-insufficient and WT mice. We tested NF-kB pathway activation as well as VEGF and HGF secretion in vitro and in vivo. We verified that pro-angiogenesis activity and cardiomyocyte protection improved the prognosis in p27 haplo-insufficient post-MI mice by promoting NF-kB activation.
Results

p27
1/-mice exhibit increased cardiac function after MI. Myocardial infarction (MI) was induced by LAD artery ligation in WT, p27 1/2 and p27 2/2 mice. Of 10 p27 2/2 mice, 8 (80%) died within 6 days of LAD artery ligation; no deaths were observed in sham, WT and p27 1/2 mice 28 days after LAD artery ligation. Thus, we chose the p27 1/2 mice, which expressed half the normal level of p27 protein in all tissues, including the heart, for subsequent experiments to determine the underlying mechanisms. At 28 days after MI, significant systolic dysfunction was observed, as assessed by the left ventricular (LV) fractional shortening (FS%) and ejection fraction (EF%) in infarcted groups compared with the controls (*p , 0.05, WT MI/p27 1/2 MI versus WT sham/p27 1/2 sham). However, LV dysfunction was attenuated in p27 1/2 mice compared with WT mice after infarction (#p , 0.05, p27
1/2 MI versus WT MI, Figure 1A ). These data suggest that the haplo-insufficiency of p27 preserves cardiac function after MI.
1/2 mice exhibit reduced cardiac injury and better heart formation after MI. TUNEL-positive cardiomyocytes were significantly less frequent in p27 1/2 mice than in WT mice (*p , 0.05, p27
1/2 MI versus WT MI). No TUNEL-positive cells were found in the sham groups ( Figure 1B) . Furthermore, to determine whether decreased p27 expression attenuates cardiac injury, we assessed the size of the fibrotic area using Masson trichrome staining of the WT and p27
1/2 hearts 28 days after MI. The fibrotic areas of the p27
hearts were 30%-40% of those of the WT post-MI hearts (*p , 0.05, p27 1/2 MI versus WT MI, Figure 1C ), consistent with previous reports. Heart formation is an extremely complex process and is regulated by specific cardiac development-related transcription factors, including MEF2 and GATA4. As shown in Figure 1G and H, p27 1/2 mice exhibited significantly higher levels of MEF2c and GATA4 than WT mice after MI. Moreover, p27 expression decreased at day 3 after MI until, at day 28, the expression of p27 was beyond the base line ( Figure 1D ).
1/2 mice exhibit enhanced cardiac angiogenesis. Angiogenesis is known to be critical in preserving cardiac function in response to ischemic stress 31 . To determine the effects of p27 haplo-insufficiency on angiogenesis after MI, we examined capillary density in the heart tissue using isolectin IB4. The capillary density in the border zone and in the remote zone of the infarcted hearts of p27 1/2 mice was significantly higher than that in WT mice after MI (#p , 0.05, yp , 0.05, p27
1/2 versus WT). Similar differences were observed between the two groups after the sham operations (*p , 0.05, p27
1/2 versus WT Figure 1E ). These data suggest that angiogenesis is greater in p27 1/2 mice than in WT mice. p27 1/2 mice exhibit enhanced VEGF and HGF expression after MI. VEGF and HGF can induce angiogenesis in the ischemic myocardium and improve cardiac function 20, 32 . To assess whether insufficient levels of p27 affect VEGF and HGF production, we analyzed VEGF and HGF expression in heart tissues using western blot analysis. As shown in Figure 2A , p27 1/2 mice exhibited significantly greater expression of VEGF/HGF and phospho-KDR/ phosphor-met than WT mice (p , 0.05, p27
1/2 versus WT). Because the effect of cytokines is associated with the activation of their receptors, we then examined the expression of phospho-KDR (the activated VEGF receptor) and phospho-Met (the activated HGF receptor) in heart tissue using immunohistochemical staining. As shown in Figure 2B , the observed phospho-KDR positive staining was limited to endothelial cells (as assessed based on their morphology) and was markedly increased in both WT and p27 1/2 hearts after MI. Moreover, the staining intensity of phospho-KDR was significantly higher in p27 1/2 hearts than in WT hearts. Phospho-Met positive cells were found only in MI cardiomyocytes (as assessed based on their morphology), and the staining intensity in p27 1/2 hearts was significantly greater than in WT hearts ( Figure 2B ). These results establish that reduced levels of p27 have important anti-apoptotic effects and promote angiogenesis in the infarcted heart through the up-regulation of VEGF and HGF.
Hypoxia and TNF-a up-regulate VEGF and HGF. Hypoxia and inflammation are the initial conditions resulting from MI. To determine the mechanisms underlying the roles of VEGF and HGF in cardiac repair after MI, we examined the effects of hypoxia and TNF-a (10 ng/ml for 2 h), a key cytokine associated with inflammation, on VEGF and HGF expression in the rat myocardial cell line, H9c2. Western blotting analysis demonstrated a marked increase in VEGF and HGF expression after TNF-a and hypoxia treatment (p , 0.05 immediately after treatment, Figure 3A ). According an ELISA ( Figure 3B ), H9c2 cells secreted VEGF and HGF, and this secretion increased 4 and 5-fold, respectively, when the cells were cultured in hypoxic conditions (#p , 0.05, Hypoxia WT/Hypoxia p27 knockdown versus NC WT/NC p27 knockdown , Figure 3B ). In contrast, VEGF and HGF were expressed at significantly higher concentrations in p27 knockdown H9c2 cells than in WT cells under both normal and hypoxic conditions (*p , 0.05, NC p27 knockdown / Hypoxia p27 knockdown versus NC WT/Hypoxia WT, Figure 3B ). Meanwhile, the control group did not differ significantly from the WT group. These data indicated that hypoxia promotes the production of VEGF and HGF and that decreases in the level of p27 enhance this effect. Reduced heart injury is mediated through VEGF and HGF. To verify the cytoprotective effect of VEGF and HGF on cardiomyocytes, we measured the levels of cleaved caspase-3 and Bcl2 expression in H9c2 cells using western blot analysis. The cells were exposed to hypoxia for 12 h to mimic post-MI conditions and then treated with or without conditioned medium (CM) from hypoxia-treated p27-knockdown cells, mimicking their autocrine action. Neutralizing antibodies for VEGF and HGF were added to the CM to confirm their effects. As shown in Figure 4A , treatment with hypoxia for 12 h significant increased the levels of cleaved caspase-3 and decreased the expression of Bcl2 in H9c2 cells (12 h versus NC), indicating that hypoxia exerted a pro-apoptotic effect. These alterations in expression levels were significantly attenuated by CM treatment. Moreover, the inhibition of apoptosis by CM was partially reversed by VEGF or HGF neutralizing antibodies and was almost completely reversed when both antibodies were used in combination (CM 1 anti-VEGF&HGF versus CM). HGF affected the expression of phospho-Met in H9c2 cells. Thus, the cytoprotective function of CM on cardiomyocytes is mediated by VEGF and HGF.
Enhanced cardiac angiogenesis is mediated through VEGF and HGF. To verify the angiogenic effects of VEGF and HGF on the heart, we tested the effects of CM on HUVEC proliferation, migration and tube formation. HUVECs were treated with CM as previously described. As shown in Figure 4E and F, after treatment with CM, HUVEC proliferation significantly increased; HUVEC proliferation was attenuated by VEGF or HGF neutralizing antibodies and almost completely reversed when the two antibodies were used in combination. Similar results were found for the HUVEC migration and tube formation assays (*p , 0.05, CM/CM 1 HGF antibody/CM 1 VEGF antibody versus NC; Figure 4B , C, D). The expression of phospho-KDR and phospho-Met in HUVECs also revealed the activating effect of VEGF and HGF ( Figure 4E ). These results indicate that the angiogenic effects of CM are mediated by VEGF and HGF. p27 interacts with the NF-kB activator IKK. To study the p27-IKK interaction, we performed co-immunoprecipitation (Co-IP) experiments on WT mouse heart tissue lysates. As expected, binding was detected between endogenous IKKa, IKKb and p27 in heart tissue ( Figure 5A ). To verify that p27 and IKK interact directly in vitro, we used a lentivirus vector to generate a stable p27 knockdown derivative of the H9c2 cell line (approximately 50% efficiency) and subjected it to hypoxia and TNF-a treatment. The phosphorylated of NF-kB activator (levels of phospho-IKKa/b) and its downstream phospho-p65 appeared to be enhanced by p27 knockdown and was associated with increased VEGF and HGF expression (*p , 0.05, 3 h/TNF-a versus 0 h, Figure 5B ). Furthermore, we examined whether p27 affected the phosphorylation of endogenous IKK in response to MI in vivo. Indeed, IKKa and b were phosphorylated, and its downstream phospho-p65 was significantly enhanced in p27 1/2 hearts at both 3 and 28 days after MI (p , 0.05, p27
1/2 versus WT, Figure 5C ). These data indicate that p27 interacts with IKK both in vivo and in vitro.
Enhanced expression of VEGF and HGF is mediated through p27 haplo-insufficiency and IKK a/b. To confirm the association of VEGF and HGF expression with p27 and IKKa and b, we transfected siRNA for IKKa or IKKb into the p27-knockdown H9c2 cells and examined VEGF and HGF expression using western blot analyses. As shown in Figure 6A , the VEGF and HGF expression were both increased in cells after treatment with hypoxia for 3 h and were significantly attenuated by IKKa and IKKb siRNAs (*p , 0.05, #p , 0.05, si-IKKa/si-IKKb versus NC). These results were confirmed by treatment of the same cells with the IKKa/b inhibitor ACHP (*p , 0.05, p27 knockdown 3 h ACHP versus p27 knockdown 0 h; Figure 6B ). These results suggest that the production of VEGF and HGF is induced by IKK activation and enhanced by p27 insufficiency.
Discussion
Damaged myocardium is replaced by fibrotic scar tissue, which compromises the contractile function of the surviving myocardium, ultimately leading to heart failure. Reactivation of the cell cycle in surviving cardiomyocytes is one strategy that can augment the number of myocytes in the diseased hearts. Potential therapeutics for MI focus on the characterization of existing models and on the combinatorial testing of various cell cycle regulators to identify the genes and/or pathways that promote cardiomyocyte proliferation. Many cell-cycle regulatory genes, including p27 32, 33 , have been validated by generating transgenic models with the desired gene expression patterns and evaluating their regenerative response to experimentally induced injury. Because p27 is only one component of the timing mechanism for cell cycle arrest, it cannot enable cells to exit the cell cycle by itself 33 , and the partial loss of p27 might prevent cellular hypertrophy 32 . As shown in our experiments, diminished survival was found in p27 2/2 mice at the earliest stages after MI but not in WT and p27
mice. In contrast, p27 haplo-insufficient mice exhibited significant decreases in apoptosis and infarct size during early stages post MI. Improved heart function, decreased myocardium damage and increased angiogenesis were observed in p27 1/2 mice. The results revealed that p27 haplo-insufficiency plays a positive role during the early stages of post-MI repair. Moreover, following the progression of MI, p27 expression was up-regulated in both p27
1/2 and WT mice. This regulation indicates that p27 exhibits its inhibitory effect in WT and in p27 1/2 mice after the acute phase. This effect might prevent long-term ventricular decompensation remodeling and dietinduced atherosclerosis, and the partial reservation of p27 could be qualified 27, 34 . Therefore, haplo-insufficiency (but not deletion) of p27 might mitigate heart injury.
Growth factors and cytokines directly activate cell growth, differentiation and survival in an autocrine-or paracrine-dependent manner in many cells. Both VEGF and HGF are crucial due to their regenerative potential; therefore, these proteins are potential candidates for therapeutic application [35] [36] [37] . Administering VEGF or HGF to cardiac cells or increasing the production of VEGF and HGF by gene transfer technology could be used to treat heart failure and improve cardiac function 38 . In this study, a significant increase in VEGF and HGF expression and their activated receptors in hearts affected by MI revealed that they play an important adaptive role after heart injury. More importantly, our results indicated that the reductions in apoptosis and infarct size and improvements in heart function and enhanced angiogenesis caused by p27 haplo-insufficiency in MI subsequently increased the production of VEGF and HGF. Similar results were observed in in vitro studies using hypoxic and ischemic cardiomyocyte models, thus suggesting the same conclusion. p27 is a potent inhibitor of cell growth and division, and p27 insufficiency might promote cell differentiation and proliferation 11, 37, 39 . VEGF and HGF also play an essential role in cardiac cellular reprogramming after MI 40 . Consistent with these observations, cardioprotection was enhanced in p27 1/2 mice after MI in our study, and a beneficial effect on heart injury was indicated.
The main function of p27 is to inhibit the kinase activity of cyclin dependent kinase (CDK) holoenzyme, resulting in cell-cycle arrest 41 . However, p27 also regulates motility and cell survival, suggesting that its role extends beyond cell-cycle regulation 42 . In this study, the phosphorylated of NF-kB activator was demonstrated in MI mice and enhanced by p27 haplo-insufficiency. Additionally, a p27-knockdown cardiac cell line exhibited greater sensitivity to IKK a and b phosphorylation than WT cells when subjected to both hypoxia/ischemia and TNF-a treatment (which mimic MI conditions in vivo). A co-IP experiment demonstrated that p27 could bind to the IKK a and b. Therefore, p27 knockdown might enhance the IKK a and b phosphorylation through the loss of its binding to IKK. In support of this idea, our data showed that the IKKi or IKK inhibitor ACHP reversed the increased expression of VEGF and HGF in response to hypoxia/ischemia or to TNF-a exposure.
Based on our data, we propose the following model: heart ischemic injury increases the production of VEGF and HGF, thus preventing or inhibiting the progression of heart failure through NF-kB activation. p27 haplo-insufficiency enhances VEGF and HGF expression, protecting cardiomyocytes and improving cardiac angiogenesis and cardiac function. Importantly, in the hypoxia/ischemia condition, cardiomyocytes overexpressing p27 were less viable than WT or p27-knockdown cells. This suggests that p27 does not play a repair role during early stages post MI.
Karla et al. reported that endogenous TNF-a (a potent activator of NF-kB), which is produced during the early phase of myocardial ischemia, protects cardiac myocytes against ischemic-induced apoptosis 43 and increases the expression of anti-apoptotic factors 44 . Subsequent reports have indicated that inflammation and the development of small blood vessels might limit immediate damage during a subsequent heart attack 45 . Our research provides evidence that NF-kB activation caused by p27 haplo-insufficiency might protect injured hearts during the early stages post MI. Further investigation into the physiological significance of p27 would be useful due to the potential of p27 as a target for heart failure therapy.
Methods
All reagents, siRNAs and shRNAs used in this study are described in the Supplementary Materials. All experiments were performed in accordance with relevant guidelines and regulations.
Animals. All procedures and protocols used in the present study were approved by the Nanjing Medical University Animal Care Committee and followed the guidelines of the NIH Guide for the Care and Use of Laboratory Animals. The p27-knockout (p27
) and strain-specific 129S4 control mice (p27
, WT) were bred from a breeding pair of heterozygous p27 mice (gifts from Prof. Dengshun Miao, McGill University, Montreal, Canada) and were held in the Animal Research Center of Nanjing Medical University. The mice were bred in the SPF rodents' feeding room and maintained under appropriate conditions of temperature and humidity. Tail fragment genomic DNA was isolated using the standard phenol-chloroform extraction and isopropanol precipitation methods. The mouse genotypes were determined by PCR using tail fragment DNA as the template and the following primers: for the p27-knockout allele, the 59 primer was CTCTCTATCGCCTTCTTG and the 39 primer was TGGAACCCTGTGCCATCTCTAT; for the p27 wild type allele, the 59 primer was GATGGACGCCAGACAAGC and the 39 primer was ACGGGCTTATGATTCTGAAAGTCG. Three-month-old adult male C57BL/6 wild-type (p27 1/1 ), haplo-insufficient p27 (p27
), and p27-knockout (p27
) mice (10 per group) were randomly assigned to the MI and control groups. LAD artery ligation was used to induce MI as described. Sham animals underwent every procedure except coronary artery ligation. During the experimental trials, all mice had ad libitum access to the diet.
Cardiac Function Assessment. Experimental animals were assessed using echocardiography to evaluate cardiac function as previously described 30 . LV-enddiastolic (LVEDD) and LV-end-systolic dimensions (LVESD) were obtained using a Vevo 2100 ultrasound system (Visual Sonic Inc., Canada) equipped with a 30-MHz transducer. Fractional shortening (FS) was defined as [(LVEDD-LVESD)/LVEDD] 3 100. The ejection fraction (EF) was defined as [(LVEDD3-LVESD3)/LVEDD3] 3 100. For all measurements, three values were averaged for each parameter.
Histology. Heart tissues were collected from the left ventricle of mice 28 days post MI and then fixed, embedded, cut into 5-mm-thick sections and stained using HE and Masson's Trichrome.
TUNEL staining. Apoptotic nuclei were detected by in situ terminal deoxynucleotidyltransferase-mediated digoxigenin-conjugated dUTP nick-end labeling (TUNEL) using an In Situ Cell Apoptosis Detection Kit (Roche) according to the manufacturer's instructions.
Capillary density measurement. Sections were incubated with FITC-conjugated Griffonia simplicifolia lectin (Isolectin B4 1520, Vector Lab, CA, USA) and mounted with VectashieldH mounting medium. Images were collected in the infarction remote zone and the infarction border zone in mice using an Olympus BX51 microscope equipped with a 103 objective. To quantify the vasculature, four independent fields (900 mm 3 900 mm) were chosen randomly, and isolectin B4 positive cells were captured and analyzed using NIS Elements Basic Research Software version 2.30 (Nikon Instruments Inc., NY, USA).
Immunohistochemistry. After antigen retrieval and blocking, sections were incubated overnight at 4uC with the primary antibodies. A two-step technique was used for visualization; DAB (SK-4100 from Vector Laboratories, CA, USA) was used as the chromogen, and hematoxylin was used as the counterstain. Phosphor-KDR (#4991 15200 from CST, MA, USA) and phosphor-met (#3077 15200, from CST, MA, USA) were used to detect VEGF and HGF activated receptors, respectively.
Western Blot Analysis. Tissues and cells were lysed in RIPA buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na 2 EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 1 mg/ml leupeptin). The proteins were resolved using 10% SDS-PAGE and transferred to polyvinylidene difluoride membranes (IPVH00010 from Millipore, MA, USA). After blocking, the membranes were incubated with primary antibodies and subsequently incubated with horseradish peroxidase-conjugated secondary antibodies. The resulting immunocomplexes were visualized using fluorography, as enhanced by the electrochemiluminescence system (WBKLS0100 from Millipore, MA, USA). Immunoprecipitation. Heart tissue lysates were incubated with antibodies and protein G-agarose beads overnight at 4uC. The beads were washed and heated in 60 ml of SDS sample buffer, after which the proteins were resolved using 10% SDS-PAGE.
Cell culture and treatment. The rat myocardiac cell line H9c2 (2-1) (#GNR5, obtained from the cell bank of the Chinese Academy of Science, Shanghai, China) and human umbilical vein endothelial cells (HUVECs) (pcs-100-013, obtained from the American Type Culture Collection, MA, USA) were seeded at 1.25 3 10 4 cells per well in 6-well culture plates and allowed to grow for 2 days in DMEM (11995-065 from Gibco, CA, USA) containing 10% FBS (10099-141 from Gibco, CA, USA), 100 U/mL penicillin and 100 mg/mL streptomycin (450-201-EL from Winsent Inc., CA, USA). The cells were then treated as described in the figure legends. TNF-a was added to the cell culture dishes at a final concentration of 10 ng/ml for 2 hours.
Cell transfection and infection. siRNAs for IKKa, IKKb and their scramble controls were transfected into H9c2 cells using Lipofectamine 2000 (11668-019 from Invitrogen, CA, USA). The lentivirus vector pLV-p27/kip1-inhibitor (GeneChem, Shanghai, China) and the p27overexpress plasmid (GeneChem, Shanghai, China) were used to establish stable knockdown and overexpressing cell lines from H9c2. The cells were incubated with the lentivirus vector and the plasmid in the presence of 2 mg/ml polybrene overnight and then selected using 2 mg/ml puromycin (P9620 from Sigma-Aldrich, CA, USA) to obtain stably transfected cells.
Conditioned medium preparation. H9c2 cells were washed with PBS, incubated in serum-free DMEM for 24 h and then treated with or without hypoxia in serum-free DMEM for a further 12 h. The conditioned media were collected, centrifuged at 7500 3 g for 20 min in 3 k centrifugal filter devices (AMICON ULTRA-4 from Millipore, MA, USA) to concentrate the samples from 10 ml to 10 ml and then stored at 280uC for further experiments.
Enzyme-linked immunosorbent assay (ELISA). HGF and VEGF levels in the media were assessed in triplicate using the QuantikineH RAT HGF and VEGF Immunoassays as described by the manufacturer. The colorimetric absorbance was determined using a microplate absorbance reader (Bio-Tek Elx800, USA), and the protein content was calculated using standard curves for recombinant HGF or VEGF.
EdU(5-ethynyl-2-deoxyuridine) incorporation assays. Incorporated EdU was detected using Click-iTH EdU Imaging Kits (C10337 from Invitrogen, CA, USA) according to the manufacturer's instructions. The cells were photographed using a fluorescent microscope (Olympus BX51 from Olympus, Tokyo, Japan), and the images were processed using Image J software (NIH). At least 50 cells were randomly selected from a single captured field. Values presented in the text are the averages calculated from five different fields.
Migration analysis. HUVEC migration was determined using a polycarbonate membrane cell culture insert (#3421 from Corning Inc., NY, USA). Cells were resuspended in DMEM containing 1% FBS in the presence or absence of conditioned media and were seeded onto the top of the wells at a density of 1 3 10 5 cells/well. Cells were allowed to migrate through the pores in the culture insert, which was filled with medium containing 10% FBS, for 6 h. Cells on the lower surface of the membrane were fixed and stained using Giemsa and counted and evaluated at 400-fold magnification.
Tube formation analysis. 1-2 3 10 4 HUVECs were seeded in 12-well plates coated with Matrigel (#356234 from BD Biosciences, NJ, USA). After 24 h, tube formation was visualized at 103 magnification using light microscopy. Tube formation was quantified by tracing along the tubes using Image J software (NIH). The number of traces per 8-bit jpeg image was quantified based on 10 different culture dishes.
Cell counting kit-8 (CCK-8) assay. Cell proliferation was measured using the cell counting kit-8 (CCK-8) assay (Dojindo, Kumamoto, Japan). Cells were seeded in triplicate in 96-well plates, and various treatments were applied. After these treatments, CCK-8 solution (10 mL) was added to each well, and the wells were incubated for a further 2 h at 37uC. The absorbance was then measured at 450 nm (Bio-Tek, Elx800, USA).
Statistical analysis. Data from at least three independent experiments were used to calculate the means 6 SEM using SPSS 19.0 statistical software. Differences among the treatment groups were analyzed using Student's t-test or one-way ANOVA, followed by the Student-Newman-Keuls (SNK) test.
